CN Patent

CN109689654A — 7-取代的1-吡啶基-萘啶-3-甲酰胺类及其用途

Assigned to Bayer AG · Expires 2019-04-26 · 7y expired

What this patent protects

本申请涉及新的7‑取代的1‑吡啶基萘啶‑3‑甲酰胺类，其制备方法，其单独或在组合中用于治疗和/或预防疾病的用途，以及其用于制备用于治疗和/或预防疾病，特别是用于治疗和/或预防心血管疾病和/或肾病的药物的用途。

USPTO Abstract

本申请涉及新的7‑取代的1‑吡啶基萘啶‑3‑甲酰胺类，其制备方法，其单独或在组合中用于治疗和/或预防疾病的用途，以及其用于制备用于治疗和/或预防疾病，特别是用于治疗和/或预防心血管疾病和/或肾病的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN109689654A
Jurisdiction
CN
Classification
—
Expires
2019-04-26
Drug substance claim
No
Drug product claim
No
Assignee
Bayer AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.